BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 31366901)

  • 1. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
    Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
    Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity.
    Mansourizadeh F; Alberti D; Bitonto V; Tripepi M; Sepehri H; Khoee S; Geninatti Crich S
    Colloids Surf B Biointerfaces; 2020 Jul; 191():110982. PubMed ID: 32220813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies.
    Askar MA; El Shawi OE; Abou Zaid OAR; Mansour NA; Hanafy AM
    Tumour Biol; 2021; 43(1):225-247. PubMed ID: 34542050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.
    Wang W; Chen T; Xu H; Ren B; Cheng X; Qi R; Liu H; Wang Y; Yan L; Chen S; Yang Q; Chen C
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29966245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
    Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
    Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved synergic therapeutic effects of chemoradiation therapy with the aid of a co-drug-loaded nano-radiosensitizer under conventional-dose X-ray irradiation.
    Nosrati H; Charmi J; Abhari F; Attari E; Bochani S; Johari B; Rezaeejam H; Kheiri Manjili H; Davaran S; Danafar H
    Biomater Sci; 2020 Aug; 8(15):4275-4286. PubMed ID: 32589170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Int J Pharm; 2010 Oct; 398(1-2):190-203. PubMed ID: 20655375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models.
    Lübtow MM; Nelke LC; Seifert J; Kühnemundt J; Sahay G; Dandekar G; Nietzer SL; Luxenhofer R
    J Control Release; 2019 Jun; 303():162-180. PubMed ID: 30981815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGMD/curcumin nanoparticles for the treatment of breast cancer.
    Kumari M; Sharma N; Manchanda R; Gupta N; Syed A; Bahkali AH; Nimesh S
    Sci Rep; 2021 Feb; 11(1):3824. PubMed ID: 33589661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
    Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
    J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.